B.M.S.R. Nayakar and Muddu Surendra Nehru 2021. To Evaluate the efficacy and safety profile of Rosuvastatin, Simvastatin and Atorvastatin in Newly Diagnosed Type 2 Diabetic patients with Dyslipidaemia. International Journal of Health and Clinical Research. 4, 13 (Jul. 2021), 321–325.